Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Regulatory News (PRTC)

Share Price Information for PureTech (PRTC)

Share Price is delayed by 15 minutes
Get Live Data
124.20    -2.00 (-1.58%)
Bid:
123.60
Ask:
124.20
Spread: 0.60 (0.485%)
Market Cap: £302.33m
PRTC Live PriceLast checked at - London Stock Exchange

Intraday PureTech Share Chart

Transaction in Own Shares

30 Oct 2023 07:00

RNS Number : 6138R
PureTech Health PLC
30 October 2023
 

30 October 2023

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:

27 October 2023

Number of ordinary shares purchased:

37,010

Highest price paid per share:

158.80p

Lowest price paid per share:

152.40p

Volume weighted average price paid per share:

155.40p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 15,870,661 ordinary shares in treasury and has 273,597,498 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 273,597,498 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

27/10/2023

08:01:23

507

155

XLON

00375721589TRLO0.1.1

27/10/2023

08:01:23

448

155

CHIX

00375721588TRLO0.1.1

27/10/2023

08:01:23

6

155

XLON

00375721590TRLO0.1.1

27/10/2023

08:01:26

201

154.4

AQXE

00375721607TRLO0.1.1

27/10/2023

08:31:43

458

156.4

XLON

00375728714TRLO0.1.1

27/10/2023

08:31:43

55

156.6

XLON

00375728715TRLO0.1.1

27/10/2023

08:42:31

233

157.8

XLON

00375731209TRLO0.1.1

27/10/2023

08:42:31

232

158.2

XLON

00375731210TRLO0.1.1

27/10/2023

08:42:31

48

158.2

XLON

00375731211TRLO0.1.1

27/10/2023

10:03:57

95

158.2

CHIX

00375748773TRLO0.1.1

27/10/2023

10:03:57

19

158.2

CHIX

00375748772TRLO0.1.1

27/10/2023

10:03:57

495

158.2

CHIX

00375748774TRLO0.1.1

27/10/2023

10:03:57

232

158.2

CHIX

00375748775TRLO0.1.1

27/10/2023

10:03:57

201

158.2

AQXE

00375748776TRLO0.1.1

27/10/2023

10:03:57

55

158.2

CHIX

00375748778TRLO0.1.1

27/10/2023

10:03:57

201

158.2

AQXE

00375748777TRLO0.1.1

27/10/2023

10:03:59

291

158.8

XLON

00375748785TRLO0.1.1

27/10/2023

10:03:59

521

158.8

XLON

00375748784TRLO0.1.1

27/10/2023

10:04:39

94

158.8

XLON

00375748912TRLO0.1.1

27/10/2023

10:05:37

271

158.8

XLON

00375749193TRLO0.1.1

27/10/2023

10:06:12

350

158.8

XLON

00375749271TRLO0.1.1

27/10/2023

10:06:12

5

158

XLON

00375749272TRLO0.1.1

27/10/2023

10:08:45

56

158

BATE

00375749642TRLO0.1.1

27/10/2023

10:09:51

330

158

BATE

00375749867TRLO0.1.1

27/10/2023

10:09:51

386

158

BATE

00375749868TRLO0.1.1

27/10/2023

10:09:51

4224

158

XLON

00375749870TRLO0.1.1

27/10/2023

10:09:51

1021

158

XLON

00375749869TRLO0.1.1

27/10/2023

10:09:51

92

157.4

TRQX

00375749872TRLO0.1.1

27/10/2023

10:09:51

92

157.4

TRQX

00375749871TRLO0.1.1

27/10/2023

10:57:52

405

157.2

XLON

00375757689TRLO0.1.1

27/10/2023

11:11:04

121

157.2

XLON

00375759393TRLO0.1.1

27/10/2023

11:11:04

240

157.2

XLON

00375759394TRLO0.1.1

27/10/2023

11:25:50

136

157.4

BATE

00375761659TRLO0.1.1

27/10/2023

11:47:17

201

156.4

AQXE

00375763983TRLO0.1.1

27/10/2023

11:47:17

16

156.4

AQXE

00375763984TRLO0.1.1

27/10/2023

11:47:17

32

156.4

AQXE

00375763985TRLO0.1.1

27/10/2023

11:47:17

28

156.4

AQXE

00375763986TRLO0.1.1

27/10/2023

11:47:17

448

156.4

CHIX

00375763988TRLO0.1.1

27/10/2023

11:47:17

636

156.4

BATE

00375763987TRLO0.1.1

27/10/2023

11:47:17

32

156.4

CHIX

00375763989TRLO0.1.1

27/10/2023

11:47:17

1026

156.4

XLON

00375763990TRLO0.1.1

27/10/2023

11:47:22

92

156.4

TRQX

00375763996TRLO0.1.1

27/10/2023

11:49:30

365

155.6

XLON

00375764189TRLO0.1.1

27/10/2023

11:56:02

261

154.6

XLON

00375764913TRLO0.1.1

27/10/2023

12:02:46

353

154.6

XLON

00375765974TRLO0.1.1

27/10/2023

12:02:49

532

155.6

XLON

00375765979TRLO0.1.1

27/10/2023

12:02:49

180

155.6

XLON

00375765980TRLO0.1.1

27/10/2023

12:07:41

277

155.6

XLON

00375766531TRLO0.1.1

27/10/2023

12:12:04

42

154.6

TRQX

00375767220TRLO0.1.1

27/10/2023

12:12:39

319

154.6

XLON

00375767321TRLO0.1.1

27/10/2023

12:26:42

93

154.6

XLON

00375769214TRLO0.1.1

27/10/2023

12:26:42

219

154.6

XLON

00375769215TRLO0.1.1

27/10/2023

12:44:34

50

154.6

TRQX

00375771924TRLO0.1.1

27/10/2023

12:44:34

53

154.6

XLON

00375771925TRLO0.1.1

27/10/2023

12:44:34

280

154.6

XLON

00375771926TRLO0.1.1

27/10/2023

12:44:37

43

154.6

TRQX

00375771928TRLO0.1.1

27/10/2023

12:44:37

16

154.6

TRQX

00375771929TRLO0.1.1

27/10/2023

12:44:37

33

154.6

TRQX

00375771930TRLO0.1.1

27/10/2023

12:44:37

329

154.6

XLON

00375771931TRLO0.1.1

27/10/2023

12:44:37

222

154.6

XLON

00375771932TRLO0.1.1

27/10/2023

12:44:37

598

154.6

XLON

00375771933TRLO0.1.1

27/10/2023

12:44:37

61

154.2

CHIX

00375771934TRLO0.1.1

27/10/2023

12:44:37

36

154.2

CHIX

00375771935TRLO0.1.1

27/10/2023

12:44:37

43

154.2

CHIX

00375771936TRLO0.1.1

27/10/2023

12:44:40

276

154.2

CHIX

00375771945TRLO0.1.1

27/10/2023

12:44:40

49

154.2

CHIX

00375771946TRLO0.1.1

27/10/2023

12:44:40

131

154.2

CHIX

00375771948TRLO0.1.1

27/10/2023

12:59:53

75

154

BATE

00375774263TRLO0.1.1

27/10/2023

12:59:53

119

154

BATE

00375774264TRLO0.1.1

27/10/2023

13:29:32

53

154

XLON

00375779011TRLO0.1.1

27/10/2023

13:29:32

325

154

XLON

00375779012TRLO0.1.1

27/10/2023

13:34:20

280

154.8

XLON

00375780010TRLO0.1.1

27/10/2023

13:34:20

143

154.8

XLON

00375780011TRLO0.1.1

27/10/2023

14:22:54

136

155.6

AQXE

00375789842TRLO0.1.1

27/10/2023

14:30:06

312

154.6

CHIX

00375791970TRLO0.1.1

27/10/2023

14:30:07

190

155.6

AQXE

00375792052TRLO0.1.1

27/10/2023

14:34:16

130

154.6

CHIX

00375795669TRLO0.1.1

27/10/2023

14:34:16

67

154.6

CHIX

00375795671TRLO0.1.1

27/10/2023

14:34:16

197

154.6

CHIX

00375795670TRLO0.1.1

27/10/2023

14:34:16

386

154.6

BATE

00375795672TRLO0.1.1

27/10/2023

14:34:16

1026

154.6

XLON

00375795673TRLO0.1.1

27/10/2023

14:35:19

907

154

XLON

00375796273TRLO0.1.1

27/10/2023

14:35:19

240

154

XLON

00375796275TRLO0.1.1

27/10/2023

14:35:19

201

154.4

AQXE

00375796274TRLO0.1.1

27/10/2023

14:35:19

356

154

XLON

00375796276TRLO0.1.1

27/10/2023

14:54:32

386

154

BATE

00375807686TRLO0.1.1

27/10/2023

14:54:32

36

154

XLON

00375807685TRLO0.1.1

27/10/2023

14:54:32

1503

154

XLON

00375807687TRLO0.1.1

27/10/2023

14:54:32

302

153.8

XLON

00375807688TRLO0.1.1

27/10/2023

14:54:32

211

153.8

XLON

00375807689TRLO0.1.1

27/10/2023

14:54:33

92

153.4

TRQX

00375807690TRLO0.1.1

27/10/2023

14:54:33

2

153.4

TRQX

00375807691TRLO0.1.1

27/10/2023

14:54:33

3

153.4

TRQX

00375807692TRLO0.1.1

27/10/2023

14:54:34

87

153.4

TRQX

00375807712TRLO0.1.1

27/10/2023

14:56:56

989

152.4

XLON

00375808685TRLO0.1.1

27/10/2023

14:56:58

359

152.4

XLON

00375808714TRLO0.1.1

27/10/2023

15:01:59

133

152.6

CHIX

00375811299TRLO0.1.1

27/10/2023

15:02:03

159

152.6

CHIX

00375811385TRLO0.1.1

27/10/2023

15:14:41

78

153.4

XLON

00375817601TRLO0.1.1

27/10/2023

15:16:25

110

153.4

XLON

00375818478TRLO0.1.1

27/10/2023

15:16:25

838

153.4

XLON

00375818479TRLO0.1.1

27/10/2023

15:16:29

220

153.2

BATE

00375818548TRLO0.1.1

27/10/2023

15:16:29

201

153.2

AQXE

00375818547TRLO0.1.1

27/10/2023

15:22:04

107

153.2

BATE

00375821055TRLO0.1.1

27/10/2023

15:24:46

438

153.2

XLON

00375822357TRLO0.1.1

27/10/2023

15:24:46

59

153.2

BATE

00375822358TRLO0.1.1

27/10/2023

15:24:46

192

153.2

BATE

00375822359TRLO0.1.1

27/10/2023

15:24:46

293

153.2

BATE

00375822360TRLO0.1.1

27/10/2023

15:24:46

416

153.2

XLON

00375822363TRLO0.1.1

27/10/2023

15:24:46

172

153.2

XLON

00375822364TRLO0.1.1

27/10/2023

15:24:46

92

153

TRQX

00375822365TRLO0.1.1

27/10/2023

15:24:46

32

153

TRQX

00375822366TRLO0.1.1

27/10/2023

15:29:23

401

153.2

XLON

00375824227TRLO0.1.1

27/10/2023

15:29:23

189

153.2

XLON

00375824228TRLO0.1.1

27/10/2023

15:42:06

535

154.4

XLON

00375830251TRLO0.1.1

27/10/2023

15:52:16

173

154.6

XLON

00375834930TRLO0.1.1

27/10/2023

16:14:07

1026

154.2

XLON

00375844986TRLO0.1.1

27/10/2023

16:14:07

1026

154.2

XLON

00375844987TRLO0.1.1

27/10/2023

16:14:07

448

153.8

CHIX

00375844988TRLO0.1.1

27/10/2023

16:14:07

513

153.6

XLON

00375844989TRLO0.1.1

27/10/2023

16:14:08

238

153.2

BATE

00375844999TRLO0.1.1

27/10/2023

16:20:01

170

154.8

CHIX

00375848403TRLO0.1.1

27/10/2023

16:25:55

89

154.8

CHIX

00375850921TRLO0.1.1

27/10/2023

16:29:02

55

154.8

XLON

00375852543TRLO0.1.1

27/10/2023

16:29:44

1

155.6

BATE

00375853032TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFFDIVLDFIV
Date   Source Headline
4th Jun 20265:37 pmRNSHolding(s) in Company
29th May 20265:00 pmRNSHolding(s) in Company
27th May 20265:30 pmRNSHolding(s) in Company
22nd May 20265:00 pmRNSHolding(s) in Company
15th May 20267:00 amRNSCorrection - Holding(s) in Company
13th May 202612:00 pmRNS-RPRTC To Showcase Deupirfenidone at ATS Conference
8th May 20267:00 amRNSHolding(s) in Company
7th May 20266:27 pmRNSHolding(s) in Company
1st May 20267:00 amRNSPureTech's Seaport Prices Upsized IPO Nasdaq: SPTX
29th Apr 20267:01 amRNSFinal Results
29th Apr 20267:00 amRNSPRTC Voluntarily Delists Nasdaq Depositary Shares
27th Apr 20266:09 pmRNSHolding(s) in Company
27th Apr 202612:05 pmRNS-RPRTC's Seaport Adds Neuropsychiatry Veteran to BOD
24th Apr 20265:58 pmRNSHolding(s) in Company
22nd Apr 202612:00 pmRNS-RPRTC's Gallop: Positive Ph1 Topline MDS & AML Data
16th Apr 20265:00 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSHolding(s) in Company
13th Apr 20267:05 amRNSNotice of Results
13th Apr 20267:00 amRNSPRTC's Seaport Files for Proposed Nasdaq IPO
1st Apr 20267:00 amRNSTotal Voting Rights
25th Mar 20266:00 pmRNS-RPRTC’s Seaport: GlyphAllo Paper Published
13th Mar 20264:35 pmRNSPDMR Notification RSU Vesting
2nd Mar 20267:00 amRNSTotal Voting Rights
25th Feb 20267:00 amRNS-RPRTC to Present at Leerink Healthcare Conference
19th Feb 20265:15 pmRNS-RPRTC's Deupirfenidone Granted FDA & EU ODD for IPF
6th Jan 202612:00 pmRNS-RPureTech to Present at the JP Morgan Conference
18th Dec 20257:00 amRNSPureTech Appoints Robert Lyne as CEO
10th Dec 20255:41 pmRNSResults of AGM on June 16, 2025 – Update Statement
10th Dec 20255:30 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNS-RPRTC: Successful FDA Meeting; IPF Phase 3 in 1H26
5th Dec 20256:00 pmRNS-RPRTC's Gallop: Positive Initial Topline AML Data
18th Nov 20255:30 pmRNSHolding(s) in Company
7th Nov 20256:18 pmRNSHolding(s) in Company
3rd Nov 20252:00 pmRNS-RPRTC: New LYT-200 AML Data + Update at ASH
22nd Oct 20257:00 amRNS-RPRTC: New IPF Data Show Benefit in Older Patients
17th Oct 20255:30 pmRNSHolding(s) in Company
14th Oct 20257:00 amRNSHolding(s) in Company
10th Oct 20255:59 pmRNSHolding(s) in Company
9th Oct 20256:10 pmRNSHolding(s) in Company
1st Oct 20257:00 amRNSHolding(s) in Company
29th Sep 20257:00 amRNS-RPRTC: New IPF Data Show Switch Patients Stabilized
24th Sep 20257:00 amRNSPDMR DEALING - PURCHASE OF SHARES
23rd Sep 20255:30 pmRNSHolding(s) in Company
19th Sep 20255:52 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSHolding(s) in Company
11th Sep 202512:05 pmRNS-RPRTC's Seaport Advances 2nd Candidate Into Clinic
4th Sep 20255:30 pmRNSHolding(s) in Company
1st Sep 20257:00 amRNSTotal Voting Rights
28th Aug 20257:00 amRNSHalf-year Report
21st Aug 202512:00 pmRNS-RPureTech Showcases Differentiated IPF Strategy

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.